The Scientific Advisory Team at Prokaryotics, composed of experienced founders and directors in chemistry, microbiology, and operations, provides strategic guidance on optimizing Merck's early-stage antibiotic programs. Their expertise helps shape the development, manufacturing, and commercialization efforts for novel therapies targeting both Gram-negative and Gram-positive bacteria.
View all